规格参数
| 项目 | 产品信息 |
|---|---|
| 认证 | CE认证 |
| HA 浓度 | 20 mg/mL |
| 面部系列 | 1 mL × 1支预充式注射器 |
| 身体系列 | 10 mL × 1支预充式注射器 |
面部型号
| 型号 | 粒径 | 针头 | 包装形式 |
|---|---|---|---|
| Soft | 200 µm | 30G / 13 mm | 1 mL × 1支预充式注射器 |
| Mid | 350 µm | 27G / 13 mm | 1 mL × 1支预充式注射器 |
| Ultra | 450 µm | 25G / 13 mm | 1 mL × 1支预充式注射器 |
身体型号
| 型号 | 粒径 | 针头 | 包装形式 |
|---|---|---|---|
| Classic-H | 400 µm | 20–21G / 50 mm | 10 mL × 1支预充式注射器 |
| Classic-S | 250 µm | 21–23G / 50 mm | 10 mL × 1支预充式注射器 |
技术与材料
目录介绍 MCL（多阶段交联）及交联 HA 微珠结构，面部系列采用超薄壁针头。资料注明原料来源为 Shiseido Co., Ltd.，并描述 DVS、MDAWO 清洗技术，所述纯度为97%或以上。
完整英文原始详情
下方保留产品指南的完整英文文本。上方本地化介绍及规格表是对资料的结构化整理；PDF 保留制造商或来源的原始文件。
A CE-certified hyaluronic acid dermal-filler collection with three face variants — Soft, Mid and Ultra — and two body variants — Classic-H and Classic-S. All five variants contain HA 20 mg/mL, with different particle sizes and delivery specifications.
Face collection: Soft, Mid and Ultra
Three face variants provide different particle sizes and needle gauges. Each contains HA 20 mg/mL in a 1 mL syringe. The catalogue specifies ultra-thin-wall needles for all three variants.
| Specification | Soft | Mid | Ultra |
|---|---|---|---|
| HA concentration | 20 mg/mL | 20 mg/mL | 20 mg/mL |
| Particle size | 200 µm | 350 µm | 450 µm |
| Needle gauge | 30G | 27G | 25G |
| Needle length | 13 mm | 13 mm | 13 mm |
| Pack | 1 mL × 1 syringe | 1 mL × 1 syringe | 1 mL × 1 syringe |
Applicable facial areas
The catalogue maps each variant to the following facial areas.
| Area | Catalogue variant |
|---|---|
| Fine wrinkles | Soft |
| Lips | Soft / Mid |
| Deep wrinkles | Mid |
| Forehead | Mid |
| Cheekbone | Ultra / Mid |
| Nose | Ultra |
| Nasolabial area | Ultra |
| Short chin | Ultra |
Body collection: Classic-H and Classic-S
The body collection contains HA 20 mg/mL and is supplied as 10 mL × 1 syringe. Classic-H and Classic-S differ in particle size and cannula specifications.
| Specification | Classic-H | Classic-S |
|---|---|---|
| HA concentration | 20 mg/mL | 20 mg/mL |
| Particle size | 400 µm | 250 µm |
| Cannula gauge | 20–21G | 21–23G |
| Cannula length | 50 mm | 50 mm |
| Pack | 10 mL × 1 syringe | 10 mL × 1 syringe |
MCL microbead architecture
MCL is described as Multi Staged Crosslinking. The catalogue presents a crosslinked HA microbead structure: ultrafine beads formed from HA molecules are united into new beads, followed by further bead assembly.
The material photograph presents K’belle Ultra in a semi-solid gel state.
- Crosslinked HA microbeads.
- Multi-stage bead architecture.
- Semi-solid gel presentation.
Raw material and manufacturing information
The catalogue names Shiseido Co., Ltd. as the raw-material source and references the European Pharmacopoeia. It describes DVS and MDAWO washing technology, with a stated purity of 97% or more.
Particle-size comparison
| Specification | Product “P” | K’belle |
|---|---|---|
| Particle size | 1,000 µm | 450 µm |
| HA concentration | 20 mg/mL | 20 mg/mL |
Material characterisation
The brochure reproduces a spectral comparison of HA raw material and finished product.
The hydrophilicity / centrifuge test uses a 1 cc sample in 500 cc water at 3,000 rpm for 30 minutes. The reported remaining amounts are shown below.
The brochure identifies these as bench observations, not clinical safety or efficacy findings, and specifies that they are not a claim of injected volume gain.
| Sample | Reported remaining amount |
|---|---|
| A | 4 cc |
| B | 4 cc |
| C | 4.5 cc |
| K’belle | 15.5 cc |
专业业务咨询
请注明公司、目的国、所选型号及数量。此操作将打开邮件应用，不会自动发送或保存咨询。
alexmoon@ictmedicalco.com ↗